Increased inflammation and lower platelet 5-HT in depression with metabolic syndrome

Journal of Affective Disorders

Volumn 141, Issue 1, 2012, Pages 72-78

  Silić, Ante ^a   Karlović, Dalibor ^b   Serretti, Alessandro ^c  

^a Sisak I Psihijatrijska Bolnica Sveti Ivan   (Croatia)

^b SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

C reactive protein; Interleukin 6; Major depressive disorder; Metabolic syndrome; Platelet serotonin

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; SEROTONIN;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DIET; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HOSPITALIZATION; HUMAN; HUMAN CELL; INFLAMMATION; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; METABOLIC SYNDROME X; PHYSICAL ACTIVITY; PRIORITY JOURNAL; THROMBOCYTE; WAIST CIRCUMFERENCE;

AGED; BLOOD PLATELETS; C-REACTIVE PROTEIN; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROSPECTIVE STUDIES; SEROTONIN;

EID: 84865499870     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2012.02.019     Document Type: Article

References (41)

1. T. Church Exercise in obesity, metabolic syndrome and diabetes Progress in Cardiovascular Diseases 53 2011 412 418
2. R.H. Eckel, S.M. Grundy, and P.Z. Zimmet The metabolic syndrome The Lancet 365 2005 1415 1428 (Pubitemid 40523737)
3. A.S. Elheuegi Central monoamines and their role in major depression Progress in Neuro-Psychopharmacology & Biological Psychiatry 28 2004 435 451
4. S.A. Everson-Rose, P.M. Meyer, L.H. Powell, D. Pandey, J.I. Torrens, H.M. Kravitz, J.T. Bromberger, and K.A. Matthews Depressive symptoms, insulin resistance and risk of diabetes in women at midlife Diabetes Care 27 2004 2856 2862 (Pubitemid 39565049)
5. A. Festa, R. D'Agostino Jr., G. Howard, L. Mykkänen, R.P. Tracy, and S.M. Haffner Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS) Circulation 102 2000 42 47 (Pubitemid 30430551)
6. A. Field Discovering Statistics using SPSS 2009 Sage Publication Ltd. London
7. M.B. First, R.L. Spitzer, and M. Gibbon Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I/P) 2002 New York State Psychiatric Institute, Biometrics Research New York
8. S. Glund, and A. Krook Role of interleukin-6 signalling in glucose and lipid metabolism Acta Physiologica 192 2008 37 48 (Pubitemid 350265360)
9. S.M. Grundy, J.I. Cleeman, S.R. Daniels, K.A. Donato, R.H. Eckel, B.A. Franklin, D.J. Gordon, R.M. Krauss, P.J. Savage, S.C. Smith, J.A. Spertus, and F. Costa Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung and Blood Institute Scientific Statement Circulation 112 2005 2735 2752 (Pubitemid 41532612)
10. M. Hamilton A rating scale for depression Journal of Neurology, Neurosurgery, and Psychiatry 23 1960 56 62
11. T.S. Han, N. Sattar, K. Williams, C. Gonzalez-Villalpando, M.E. Lean, and S.M. Haffner Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study Diabetes Care 25 2002 2016 2021 (Pubitemid 41071061)
12. T.H. Heiskaanene, L.K. Niskanen, J.J. Hintikka, H.T. Koivumaa-Honkanen, K.M. Honkalampi, K.M. Haatainem, and H.T. Viinamaki Metabolic syndrome and depression: a cross-sectional analysis The Journal of Clinical Psychiatry 67 2006 1422 1427 (Pubitemid 44583390)
13. R. Herrera-Marquez, J. Hernandez-Rodriguez, J. Medina-Serrano, A. de Oca Boyzo-Montes, and G. Manjarrez-Gutierrez Association of metabolic syndrome with reduced central serotonergic activity Metabolic Brain Disease 26 2011 29 35
14. J. Horacek, M. Kuzmiakova, C. Hoschl, M. Andel, and R. Bahbonh The relationship between central serotonergic activity and insulin sensitivity in healthy volunteers Psychoneuroendocrinology 24 1999 785 797 (Pubitemid 29461052)
15. M.B. Howren, D.M. Lamkin, and J. Suls Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis Psychosomatic Medicine 71 2009 171 186
16. L.S. Kinder, M.R. Carnethon, L.P. Palaniappan, A.C. King, and S.P. Fortmann Depression and the metabolic syndrome in young adults: findings from the Third National Health and Nutrition Examination Survey Psychosomatic Medicine 66 2004 316 322 (Pubitemid 38668398)
17. H. Koponen, J. Jokelainen, S. Keinanen-Kiukaanniemi, E. Kumpusalo, and M. Vanhala Metabolic syndrome predisposes to depressive symptoms: a population-based 7-year follow-up study The Journal of Clinical Psychiatry 69 2008 178 182 (Pubitemid 351469259)
18. I. Kowalska, M. Straczkowski, A. Nikolajuk, A. Adamska, M. Karczewska-Kupczewska, E. Otziomek, I. Kinalska, and M. Gorska Insulin resistance, serum adiponectin, and proinflammatory markers in young subjects with the metabolic syndrome Metabolism 57 2008 1539 1544
19. Y. Liang, S. Luo, and A.H. Cincotta Long-term infusion of norepinephrine plus serotonin into the ventromedial hypothalamus impairs pancreatic islet function Metabolism 48 1999 1287 1289 (Pubitemid 29496077)
20. I. Lucki The spectrum of behaviors influenced by serotonin Biological Psychiatry 44 1998 151 162 (Pubitemid 28378297)
21. M. Maes Evidence for an immune response in major depression: a review and hypothesis Progress in Neuro-Psychopharmacology and Biological Psychiatry 19 1995 11 38
22. M. Maes, B.E. Leonard, A.M. Myjnt, M. Kubera, and R. Verkerk The new "5-HT" hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression Progress in Neuro-Psychopharmacology and Biological Psychiatry 35 2011 702 721
23. M. Maes, M. Kubera, E. Obuchowiczwa, L. Goehler, and J. Brzeszcz Depression's multiple comorbidities explained by (neuro) inflammatory and oxidative & nitrosative stress pathways Neuro Endocrinology Letters 32 2011 7 24
24. M. Maes, P. Galecki, Y.S. Chang, and M. Berk A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness Progress in Neuro-Psychopharmacology and Biological Psychiatry 35 2011 676 692
25. R.B. McCall, and M.E. Clement Role of serotonin 1A and serotonin 2 receptors in the central regulation of the cardiovascular system Pharmacological Reviews 46 2001 231 243
26. R.S. McIntyre, K.Y. Park, C.W. Law, F. Sultan, A. Adams, M.T. Lourenco, A.K. Lo, J.K. Soczynska, H. Woldeyohannes, M. Alsuwaidan, J. Yoon, and S.H. Kennedy The association between conventional antidepressants and the metabolic syndrome: a review of the evidence and clinical implications CNS Drugs 24 2010 741 753
27. M.F. Muldoon, R.H. Mackey, K.V. Williams, M.T. Korytkowski, J.D. Flory, and S.B. Manuck Low central nervous system serotonergic responsivity is associated with the metabolic syndrome and physical inactivity The Journal of Clinical Endocrinology and Metabolism 89 2004 266 271 (Pubitemid 38183892)
28. M.F. Muldoon, R.H. Mackey, M.T. Korytkowski, J.D. Flory, B.G. Pollock, and S.B. Manuck The metabolic syndrome is associated with reduced central serotonergic responsivity in healthy community volunteers The Journal of Clinical Endocrinology and Metabolism 91 2006 718 721 (Pubitemid 43236948)
29. F. Okamura, A. Tashiro, A. Utumi, T. Imai, T. Suchi, D. Tamura, Y. Sato, S. Suzuki, and M. Hongo Insulin resistance in patients with depression and its changes during the clinical course of depression: minimal model analysis Metabolism 49 2000 1255 1260
30. L. Pulkki-Raback, M. Elovainio, M. Kivimaki, N. Mattsson, O.T. Raitakari, S. Puttonen, J. Marniemi, J.S. Viikari, and L. Keltikangas-Järvinen Depressive symptoms and the metabolic syndrome in childhood and adulthood: a prospective cohort study Health Psychology 28 2009 108 116
31. K. Raikkonen, K.A. Matthews, and L.H. Kuller Depressive symptoms and stressful life events predict metabolic syndrome among middle-aged women: a comparison of World Health Organization, Adult Treatment Panel III, and International Diabetes Foundation definitions Diabetes Care 30 2007 872 877 (Pubitemid 46556580)
32. A.G. Ramage Central cardiovascular regulation and 5-hydroxytryptamine receptors Brain Research Bulletin 56 2001 425 439 (Pubitemid 34031778)
33. N. Richter, G. Juckel, and H.J. Assion Metabolic syndrome: a follow-up study of acute depressive inpatients European Archives of Psychiatry and Clinical Neuroscience 260 2010 41 49
34. R. Rosmond, C. Bouchard, and P. Bjorntorp Increased abdominal obesity in subjects with a mutation in the 5-HT 2A receptor gene promoter Annals of the New York Academy of Sciences 967 2002 571 575 (Pubitemid 34721949)
35. O.G.J. Schiepers, M.C. Wichers, and M. Maes Cytokines and major depression Progress in Neuro-Psychopharmacology & Biological Psychiatry 29 2005 201 217 (Pubitemid 40202906)
36. A. Serretti, and L. Mandelli Antidepressants and body weight: a comprehensive review and meta-analysis The Journal of Clinical Psychiatry 71 2010 1259 1272
37. D.V. Sheehan, Y. Lecrubier, K.H. Sheehan, P. Amorim, J. Janavs, E. Weiller, T. Hergueta, R. Baker, and G.C. Dunbar The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 The Journal of Clinical Psychiatry S20 1998 34 57
38. K. Tamakoshi, H. Yatsuya, T. Kondo, Y. Hori, M. Ishikawa, H. Zhang, C. Murata, R. Otsuka, S. Zhu, and H. Toyoshima The metabolic syndrome is associated with elevated circulating C-reactive protein in healthy reference range, a systemic low-grade inflammatory state International Journal of Obesity and Related Metabolic Disorders 27 2003 443 449 (Pubitemid 36520842)
39. L. Thomas Clinical laboratory diagnostics Use and Assessment of Clinical Laboratory Results 1998 TH-Books Verlagsgesellschaft mbH Frankfurt, Germany
40. R. Yoshimura, H. Hori, A. Ikenouchi-Sugita, W. Umene-Nakano, N. Ueda, and J. Nakamura Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression Progress in Neuro-Psychopharmacology & Biological Psychiatry 33 2009 722 726
41. X. Yuan, K. Yamada, S. Ishiyama-Shigemoto, W. Koyama, and K. Nonaka Identification of polymorphic loci in the promoter region of the serotonin 5-HT2C receptor gene and their association with obesity and type II diabetes Diabetologia 43 2000 373 376 (Pubitemid 30163481)